Age and meloxicam attenuate the ischemia/reperfusion-induced down-regulation in the NMDA receptor genes

In the assays of ischemia/reperfusion followed by a treatment with the anti-inflammatory agent meloxicam, we observed that ischemic insult was unable to elicit changes in the NMDAR transcription, thus suggesting that inflammation plays a crucial role in the transcriptional control of these genes.